Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heinrich Resch

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Breast Care (Basel, Switzerland)|July 23, 2011
Osteoporosis: New-Generation DrugsHeinrich Resch
Wiener Medizinische Wochenschrift (1946)|January 10, 2015
[Cathepsin K antagonists: preclinical and clinical data]Marion Gamsjäger, Heinrich Resch
Wiener Medizinische Wochenschrift (1946)|February 20, 2020
Treatment of hypophosphatasiaSebastian Simon, Heinrich Resch
Archives of Osteoporosis|March 18, 2010
Management of osteoporosis in central and eastern Europe (CEE): conclusions of the "2nd Summit on Osteoporosis-CEE", 21-22 November 2008, Warsaw, PolandRoman S Lorenc, Heinrich Resch,
Journal of Clinical Medicine|November 11, 2022
Metabolic Bone Diseases-A Topic of Great DiversityHeinrich Resch, Afrodite Zendeli, Roland Kocijan
Wiener Klinische Wochenschrift|July 2, 2016
Bone microarchitecture deteriorations and a fragility fracture in a patient with beta and alpha heterozygous thalassemia: a case reportXaver Feichtinger, Roland Kocijan, Heinrich Resch, et al.
Wiener Medizinische Wochenschrift (1946)|June 2, 2009
[Osteoporosis: a challenge for prevention]Anita Rieder, Thomas Dorner, Heinrich Resch, et al.
Endoscopy|May 9, 2014
Use of the Ella Danis stent in severe esophageal bleeding caused by acute necrotizing esophagitisZora Messner, Michael Gschwantler, Heinrich Resch, et al.
Endoscopy|April 2, 2016
Use of the Ella Danis stent in esophageal bleeding due to severe reflux esophagitisMarion Gamsjäger, Adrian Heghedus, Heinrich Resch, et al.
Journal of Clinical Medicine|February 13, 2026
Drug-Induced OsteoporosisRudolf Wolfgang Gasser, Roland Kocijan, Afrodite Zendeli, et al.
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Breast Care (Basel, Switzerland)|July 23, 2011
Osteoporosis: New-Generation DrugsHeinrich Resch
Wiener Medizinische Wochenschrift (1946)|January 10, 2015
[Cathepsin K antagonists: preclinical and clinical data]Marion Gamsjäger, Heinrich Resch
Wiener Medizinische Wochenschrift (1946)|February 20, 2020
Treatment of hypophosphatasiaSebastian Simon, Heinrich Resch
Archives of Osteoporosis|March 18, 2010
Management of osteoporosis in central and eastern Europe (CEE): conclusions of the "2nd Summit on Osteoporosis-CEE", 21-22 November 2008, Warsaw, PolandRoman S Lorenc, Heinrich Resch,
Journal of Clinical Medicine|November 11, 2022
Metabolic Bone Diseases-A Topic of Great DiversityHeinrich Resch, Afrodite Zendeli, Roland Kocijan
Wiener Klinische Wochenschrift|July 2, 2016
Bone microarchitecture deteriorations and a fragility fracture in a patient with beta and alpha heterozygous thalassemia: a case reportXaver Feichtinger, Roland Kocijan, Heinrich Resch, et al.
Wiener Medizinische Wochenschrift (1946)|June 2, 2009
[Osteoporosis: a challenge for prevention]Anita Rieder, Thomas Dorner, Heinrich Resch, et al.
Endoscopy|May 9, 2014
Use of the Ella Danis stent in severe esophageal bleeding caused by acute necrotizing esophagitisZora Messner, Michael Gschwantler, Heinrich Resch, et al.
Endoscopy|April 2, 2016
Use of the Ella Danis stent in esophageal bleeding due to severe reflux esophagitisMarion Gamsjäger, Adrian Heghedus, Heinrich Resch, et al.
Journal of Clinical Medicine|February 13, 2026
Drug-Induced OsteoporosisRudolf Wolfgang Gasser, Roland Kocijan, Afrodite Zendeli, et al.
Pageof 8